Technology
Health
Medical

ViewRay

$4.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.51 (12.98%) Today
$0.00 (0.00%) As of 4:34 PM EDT after-hours

Why Robinhood?

You can buy or sell ViewRay and other stocks, options, ETFs, and crypto commission-free!

About VRAY

ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. Read More The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

Employees
221
Headquarters
Oakwood Village, Ohio
Founded
2013
Market Cap
437.25M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
6.47M
High Today
$4.57
Low Today
$3.99
Open Price
$4.00
Volume
5.51M
52 Week High
$10.73
52 Week Low
$2.76

Collections

Technology
Health
Medical
Top Movers
Therapy
2015 IPO
US
North America

VRAY News

ReutersAug 13

Edited Transcript of VRAY earnings conference call or presentation 8-Aug-19 8:30pm GMT

71

VRAY Earnings

-$0.38
-$0.29
-$0.20
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.23 per share
Actual
-$0.32 per share

More VRAY News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.